Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer

Clinical Trials

TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias

ONCOLife

Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer

Clinical Trials

Less Toxic, More Effective: RW Evidence Supports Reduced Immunotherapy Dose in Melanoma

AI

Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists

ONCOLife

Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer

ONCOLife

Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers

ONCOLife

Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery

Biotech

Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies

ONCOLife Issues

Featured Articles

Gut Bacteria Decide Whether Nutrients Feed Tumors or Fuel Immunity

13 February 2026

Researchers at Weill Cornell Medicine have demonstrated that common intestinal bacteria are not passive residents of the digestive tract; they actively regulate whether dietary nutrients promote tumor growth or enhance the immune system’s capacity to fight c...

Trending Articles

Radioligand Therapy Pluvicto Reduces Progression Risk by 28% in mHS Prostate Cancer

Lenvatinib Plus Everolimus Improves Outcomes After PD-1 Failure in Kidney Cancer

ONCOLife

6 November 2025

Novartis Invests $23 Billion to Boost Radioligand Manufacturing Capacity in Carlsbad

Pharma

11 November 2025

Ribociclib Extends Disease-Free Survival Beyond Treatment in HR+/HER2– Early Breast Cancer

ONCOLife

3 November 2025

DeLLphi-303: Tarlatamab Plus Chemo Achieves 71% Response in ES Small-Cell Lung Cancer

ONCOLife

4 November 2025

ctDNA Blood Test Guides Chemotherapy Decisions for Tailored Colon Cancer Treatment

Trodelvy Emerges as Potential New Standard for First-Line Metastatic TN Breast Cancer

ONCOLife

24 October 2025

ESMO’s Road Map for Safe and Effective Use of AI-LLMs in Cancer Care: 23 Rules from 20 Experts

AI

3 November 2025

Datroway Extends Survival by 5 Months in Metastatic Triple-Negative Breast Cancer

ONCOLife

21 October 2025

AI Analysis of Thymic Health Predicts Immunotherapy Success, Cutting Death Risk by 44%

ONCOLife

18 October 2025

Lenvatinib Plus Pembrolizumab Delivers Durable 5-Year Survival in Endometrial Carcinoma

Disarming Prostate Cancer: Dual Enzyme Blockade Weakens Tumors and Boosts Drug Response

ONCOLife

14 October 2025

Molecular Trojan Horse: Peptide Nanotubes Offer a Path to Defeat Drug-Resistant Tumors

ONCOLife

13 October 2025

Reprogramming Cancer Cell Death: A New Immune-Based Strategy for Blood Cancers

ONCOLife

12 October 2025

LED-Activated SnOx Nanoflake Therapy Destroy Tumor Cells with Precision

ONCOLife

11 October 2025